NCT02071719View on ClinicalTrials.gov

Prediction of Response to Kinase Inhibitors Based on Protein Phosphorylation Profiles in Tumor Tissue From Advanced Renal Cell Cancer Patients

TerminatedOBSERVATIONAL
Enrollment

6

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

October 31, 2017

Study Completion Date

October 31, 2017

Conditions
Renal Cell Cancer
Trial Locations (1)

1081 HV

VU Medical Center, Amsterdam

Sponsors

Lead Sponsor

M. Labots
All Listed Sponsors
lead

M. Labots

OTHER

NCT02071719 - Prediction of Response to Kinase Inhibitors Based on Protein Phosphorylation Profiles in Tumor Tissue From Advanced Renal Cell Cancer Patients | Biotech Hunter | Biotech Hunter